Gliotoxin reverses age-dependent nuclear morphology phenotypes, ameliorates motility, but fails to affect lifespan of adult Caenorhabditis elegans

Cell Motility and the Cytoskeleton

Volumn 66, Issue 10, 2009, Pages 791-797

  Bar, Daniel Z ^a   Neufeld, Ester ^a   Feinstein, Naomi ^a   Gruenbaum, Yosef ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Aging; Caenorhabditis elegans; Farnesyl transferase inhibitor; Lamin; Nuclear envelope

Indexed keywords

GLIOTOXIN; LAMIN; LAMIN A; PROTEIN FARNESYLTRANSFERASE INHIBITOR;

CAENORHABDITIS ELEGANS; CELL AGING; CELL MOTILITY; CELL NUCLEUS; CELL STRUCTURE; CONFERENCE PAPER; CONTROLLED STUDY; DOWN REGULATION; FIBROBLAST; GENE; GENE MUTATION; HUMAN; HUMAN CELL; LIFESPAN; LMNA GENE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROGERIA; PROTEIN PROCESSING; SKIN CELL; ZMPSTE26 GENE;

ANIMALS; CAENORHABDITIS ELEGANS; CELL AGING; CELL MOVEMENT; CELL NUCLEUS; FARNESYLTRANSTRANSFERASE; GLIOTOXIN; HUMANS; LAMIN TYPE A; LONGEVITY; MICROSCOPY, ELECTRON, TRANSMISSION; MOVEMENT; NUCLEAR LAMINA; PHENOTYPE;

ANIMALIA; CAENORHABDITIS ELEGANS; MUS;

EID: 70349493024     PISSN: 08861544     EISSN: 10970169     Source Type: Journal    
DOI: 10.1002/cm.20347     Document Type: Conference Paper

References (20)

1. Brandt A, Krohne G, Grosshans J. 2008. The farnesylated nuclear proteins KUGELKERN and LAMIN B promote aging-like phenotypes in Drosophila flies. Aging Cell 7:541-551. (Pubitemid 351998614)
2. Brenner S. 1974. The genetics of Caenorhabditis elegans. Genetics 77:71-94.
3. Cao K, Capell BC, Erdos MR, Djabali K, Collins FS. 2007. A lamin A protein isoform overexpressed in Hutchinson-Gilford progeria syndrome interferes with mitosis in progeria and normal cells. Proc Natl Acad Sci USA 104:3939-3954. (Pubitemid 47186157)
4. Collins JJ, Huang C, Hughe S, Kornfeld K. 2008. The measurement and analysis of age-related changes in Caenorhabditis elegans. WormBook 24:1-21. doi/10.1895/wormbook.1.137.1, available at: http://www.wormbook.org.
5. Dechat T, Shimi T, Adam SA, Rusinol AE, Andres DA, Spielmann HP, Sinensky MS, Goldman RD. 2007. Alterations in mitosis and cell cycle progression caused by a mutant lamin A known to accelerate human aging. Proc Natl Acad Sci USA 104:4955-4960. (Pubitemid 47186158)
6. Fong LG, Frost D, M M, Qiao X, Yang SH, Coffinier C, Young SG. 2006. A protein farnesyltransferase inhibitor ameliorates disease in a mouse model of progeria. Science 311:1621-1623.
7. Goldman RD, Shumaker DK, Erdos MR, Eriksson M, Goldman AE, Gordon LB, Gruenbaum Y, Khuon S, Mendez M, Varga R and others. 2004. Accumulation of mutant lamin A causes progressive changes in nuclear architecture in Hutchinson-Gilford Progeria Syndrome. Proc Natl Acad Sci USA 101:8963-8968.
8. Gruenbaum Y, Margalit A, Goldman RD, Shumaker DK, Wilson KL. 2005. The nuclear lamina comes of age. Nat Rev Mol Cell Biol 6:21-31.
9. Haithcock E, Dayani Y, Neufeld E, Zahand AJ, Feinstein N, Mattout N, Gruenbaum Y, Liu J. 2005. Age-related changes of nuclear architecture in Caenorhabditis elegans. Proc Natl Acad Sci USA 102:16690-16695. (Pubitemid 41688838)
10. Hara M, Han M. 1995. Ras farnesyltransferase inhibitors suppress the phenotype resulting from an activated ras mutation in Caenorhabditis elegans. Proc Natl Acad Sci USA 92:3333-3337.
11. Herndon LA, Schmeissner PJ, Dudaronek JM, Brown PA, Listner KM, Sakano Y, Paupard MC, Hall DH, Driscoll M. 2002. Stochastic and genetic factors influence tissue-specific decline in ageing C. elegans. Nature 419:808-814. (Pubitemid 35238561)
12. Lee SS, Lee RY, Fraser AG, Kamath RS, Ahringer J, Ruvkun G. 2003. A systematic RNAi screen identifies a critical role for mitochondria in C. elegans longevity. Nat Genet 33:40-48. (Pubitemid 36068680)
13. McClintock D, Ratner D, Lokuge M, Owens DM, Gordon LB, Collins FS, Djabali K. 2007. The mutant form of lamin A that causes Hutchinson-Gilford progeria is a biomarker of cellular aging in human skin. PLoS One 2:e1269. (Pubitemid 351722482)
14. Meta M, Yang SH, Bergo MO, Fong LG, Young SG. 2006. Protein farnesyltransferase inhibitors and progeria. Trends Mol Med 12:480-487.
15. Ramírez CL, Cadiñanos J, Varela I, Freije JM, López-Otín C. 2007. Human progeroid syndromes, aging and cancer: new genetic and epigenetic insights into old questions. Cell Mol Life Sci 64:155-170. (Pubitemid 46156885)
16. Rusiñol AE, Sinensky MS. 2006. Farnesylated lamins, progeroid syndromes and farnesyl transferase inhibitors. J Cell Sci 119:3265-3272.
17. Stewart CL, Kozlov S, Fong LG, Young SG. 2007. Mouse models of the laminopathies. Exp Cell Res 313:2144-2156.
18. Varela I, Pereira S, Ugalde AP, Navarro CL, Suárez MF, Cau P, Cadiñanos J, Osorio FG, Cobo J, de Carlos F Lévy N, Freije JM, López-Otín C. 2008. Combined treatment with statins and aminobisphosphonates extends longevity in a mouse model of human premature aging. Nat Med 14:767-772.
19. Wiesel N, Mattout A, Melcer S, Melamed-Book N, Herrmann H, Medalia O, Aebi U, Gruenbaum Y. 2008. Laminopathic mutations interfere with the assembly, localization and dynamics of nuclear lamins. Proc Natl Acad Sci USA 105:180-185.
20. Yang SH, Meta M, Qiao X, Frost D, Bauch J, Coffinier C, Majumdar S, Bergo MO, Young SG, Fong LG. 2006. A farnesyltransferase inhibitor improves disease phenotypes in mice with a Hutchinson-Gilford progeria syndrome mutation. J Clin Invest 116:2115-2121. (Pubitemid 44162320)